A Manouras, M Genetzakis, E Lagoudianakis, H Markogiannakis, A Papadima, G Kafiri, K Filis, PB Kekis, V Katergiannakis, First Department of Propaedeutic Surgery, Hippocrateion Hospital, University of Athens, Athens Medical School, Athens, Greece

Correspondence to: Andreas Manouras, MD, PhD, Associate Professor in General Surgery,1st Department of Propaedeutic Surgery, Hippocrateion Hospital, Athens Medical School, University of Athens, Q. Sophias 114, 11527, Athens,

Greece. amanouras@hippocratio.gr

Telephone: +30-697-7304422    Fax: +30-210-7707574

Received: 2007-04-05               Accepted: 2007-04-30

© 2007 WJG. All rights reserved.

Key words: Primary gastrointestinal melanomas; Unknown origin

Manouras A, Genetzakis M, Lagoudianakis E, Markogiannakis H, Papadima A, Kafiri G, Filis K, Kekis PB, Katergiannakis V. Malignant gastrointestinal melanomas of unknown origin: Should it be considered primary? World J Gastroenterol 2007; 13(29): 4027-4029

 http://www.wjgnet.com/1007-9327/13/4027.asp

TO THE EDITOR

We read with interest the article entitled: ‘Jejuno-jejunal invagination due to intestinal melanoma’ by Resta G,
et al^[1]. They reported a rare clinical case of a young woman with a bleeding jejunal melanoma, whose early clinical presentation was an intestinal invagination. The article is also referred to the rarity of gastrointestinal melanomas as well as their  possible primary nature.

We would like to make a few comments about this and  report our experience with a case series of gastrointestinal melanomas that have been proved of primary origin.

Malignant melanoma involving the gastrointestinal (GI) tract is mainly related to metastatic disease, the most common metastatic site of cutaneous melanoma^[1-3]. Usually being asymptomatic, such metastases are diagnosed pre-mortem in 1.5%-4.49% of the patients^[2-4]. GI metastases may not be clinically detected until after removal and potential cure of primary melanoma, mostly affecting the small bowel, the stomach and the colon^[2-8]. However, there is a portion of GI melanomas without any documented evidence of a primary lesion in the skin or elsewhere, even after thorough examination^[9]. Incidence of GI melanotic metastases from unknown primary origin ranges from 4% to 9% in case series. A potential metastatic nature remains difficult to be formally excluded, because they can precede the identification of a primary site and  regress spontaneously or it is too small to be identified by conventional clinical and laboratory investigations^[6]. These cases might represent melanomas primarily derived from the alimentary tract^[2,3,5,6,10]. However, they could not be documented as primary lesions because of the retrospectivity of such studies^[5,10].

Thus, identifying GI melanomas results in problems relating to histogenesis and determination of their primary or secondary nature. Primary mucosal melanomas are rare, mainly arising in head and neck, female genital tract, esophagus, anorectum and urinary tract^[2,10-12]. GI melanomas’ primary or secondary nature is often difficult to establish, giving rise to much controversies^[10-12]. Esophagus and anorectum are considered to be the most frequent sites, while their existence in the remaining part of the GI tract is still debated^[3,9]. Scattered cases, claimed to be of primitive origin, are occasionally reported in the literature^{[2,3,6,10,14-17]}.

The proposed primary sources, from which melanomas are derived, are melanoblastic cells of the neural crest, which migrate to the ileum through the omphalomesenteric canal. However, this theory can only explain ileal melanomas. This discrepancy is addressed by the theory that intestinal melanomas could originate from APUD cells, which undergo neoplastic transformation in noncutaneous sites^[14].

Over the past two decades,  we have documented five cases of solitary melanomas at the anorectum as well as the small intestine, claiming to be primary (Table 1). Our report includes three cases of melanoma located in the small intestine and two cases at the anorectum. These melanomas were considered as primitive of the gastrointestinal tract, after thorough investigation for another primary site elsewhere and a constant follow-up in patients after surgery. All underwent a thorough investigation whether they fulfill the criteria for primary GI melanomas. Clinical presentation included abdominal pain or cramping, palpable mass, diarrhea, GI bleeding, obstruction (Figure 1), intussusception or weight loss.

To establish the existence of primary GI melanomas, certain criteria have been developed. Suggestive characteristics of primitive nature include lack of concurrent or previous removal of a melanoma or atypical melanotic lesion from the skin, lack of other organ involvement, in situ change in the overlying or adjacent GI epithelium and disease free survival of 12 mo after diagnosis^[18]. The latter, recognized histologically by the presence of atypical melanotic cells in the basal layer of the epithelium and extending in a “pagetoid” fashion into the more superficial epithelium, may be reported in 40%-100% of primary GI melanomas^[5,17]. Histologically, the tumor cells show varying proportions of spindled cells and epithelioid areas, the latter is characterized by large, pleomorphic cells with large eosinophilic nucleoli and abundant cytoplasm (Figures 2 and 3). Cells frequently are poorly cohesive, particularly in the more epithelioid areas. Tumors may show abundant melanin pigment, confirmed histochemically by a Masson Fontana stain (Figure 4), within stromal macrophages and tumor cells. They may be even completely amelanotic. Stains that do not depend upon the presence of melanin pigment include S100 and the more specific HMB-45 (Figure 5). Electron microscopy demonstrates melanosomes and premelanosomes in the tumor cells. Immunohistochemical stains for HMB-45 and Masson-Fontana have increased the diagnostic sensitivity of the biopsy and cytologic evaluation.

Regardless the exact origin of the melanotic lesion of the GI tract, the treatment of choice should be a curative-intent en block resection of the tumor with sufficient free margins and mesentery (Figure 6)^[5,13]. Surgical palliation in non-curable melanomas aims at relieving obstruction and/or bleeding^[8,12]. Surgery, if curative, has a relatively low morbidity and mortality and long-term disease-free survival^[2,4,7]. Systemic adjuvant therapy has a limited role. Chemotherapy using cisplatin, dacarbazine and tamoxifen has been applied, but the response rates are extremely low^[2,15]. Melanomas that arise on mucosa surfaces appear to be more aggressive and are associated with worse prognosis than cutaneous melanomas. This may be related to delayed diagnosis, an inherently more aggressive behavior of mucosal melanomas or earlier dissemination because of the rich lymphatic and vascular supply of the GI tract mucosa.

REFERENCES

1         Resta G, Anania G, Messina F, de Tullio D, Ferrocci G, Zanzi F, Pellegrini D, Stano R, Cavallesco G, Azzena G,     Occhionorelli S. Jejuno-jejunal invagination due to intestinal melanoma. World J Gastroenterol 2007; 13: 310-312       PubMed

2         Kadivar TF, Vanek VW, Krishnan EU. Primary malignant melanoma of the small bowel: a case study. Am Surg 1992;     58: 418-422   PubMed

3         Avital S, Romaguera RL, Sands L, Marchetti F, Hellinger MD. Primary malignant melanoma of the right colon. Am     Surg 2004; 70: 649-651   PubMed

4         Ollila DW, Essner R, Wanek LA, Morton DL. Surgical resection for melanoma metastatic to the gastrointestinal tract.     Arch Surg 1996; 131: 975-980   PubMed

5         Elsayed AM, Albahra M, Nzeako UC, Sobin LH. Malignant melanomas in the small intestine: a study of 103 patients.     Am J Gastroenterol 1996; 91: 1001-1006   PubMed

6         Atmatzidis KS, Pavlidis TE, Papaziogas BT, Papaziogas TB. Primary malignant melanoma of the small intestine:     report of a case. Surg Today 2002; 32: 831-833   PubMed

7         Klaase JM, Kroon BB. Surgery for melanoma metastatic to the gastrointestinal tract. Br J Surg 1990; 77: 60-61       PubMed

8         McClenathan JH. Metastatic melanoma involving the colon. Report of a case. Dis Colon Rectum 1989; 32: 70-72       PubMed

9         Woollons A, Derrick EK, Price ML, Darley CR. Gastrointestinal malignant melanoma. Int J Dermatol 1997; 36: 129-    131   PubMed

10        Poggi SH, Madison JF, Hwu WJ, Bayar S, Salem RR. Colonic melanoma, primary or regressed primary. J Clin     Gastroenterol 2000; 30: 441-444   PubMed

11        Sutherland CM, Chmiel JS, Henson DE, Winchester DP. Patient characteristics, methods of diagnosis, and treatment     of mucous membrane melanoma in the United States of America. J Am Coll Surg 1994; 179: 561-566   PubMed

12        Gutman M, Inbar M, Chaitchik S, Merhav A, Pausner D, Skoznik Y, Ilie B, Rozin RR, Klausner JM. Malignant melanoma     of the mucous membranes. Eur J Surg Oncol 1992; 18: 307-312   PubMed

13        Tessier DJ, McConnell EJ, Young-Fadok T, Wolff BG. Melanoma metastatic to the colon: case series and review of the     literature with outcome analysis. Dis Colon Rectum 2003; 46: 441-447   PubMed

14        Amar A, Jougon J, Edouard A, Laban P, Marry JP, Hillion G. Primary malignant melanoma of the small intestine.      Gastroenterol Clin Biol 1992; 16: 365-367   PubMed

15        Letovanec I, Vionnet M, Bouzourene H. Primary appendiceal melanoma: fiction or reality? Hum Pathol 2004; 35:     627-629   PubMed

16        Lagoudianakis EE, Genetzakis M, Tsekouras DK, Papadima A, Kafiri G, Toutouzas K, Katergiannakis V, Manouras A.      Primary gastric melanoma: a case report. World J Gastroenterol 2006; 12: 4425-4427   PubMed

17        Christova S, Meinhard K, Mihailov I, Alexiev B. Three cases of primary malignant melanoma of the alimentary tract.     Gen Diagn Pathol 1996; 142: 63-67   PubMed

18        Sachs DL, Lowe L, Chang AE, Carson E, Johnson TM. Do primary small intestinal melanomas exist? Report of a case.     J Am Acad Dermatol 1999; 41: 1042-1044   PubMed

                           S- Editor  Liu Y    L- Editor  Ma JY    E- Editor  Liu Y